Anti-viral compounds
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.
Abbott Laboratories
C A A A C C
C07D A61P A61P A61P C07D C07D
inventional inventional inventional inventional inventional inventional
Darold L. Michael D. Rolf Pamela L. David D. Tami J. Akhteruzzaman Todd W. Nobuhiko David J. Rong Allan C. Curt S. Wenping Dale J. Christopher E. John K. Keith F. Liangjun Hongmei Clarence J. Robert J. Brian E. David A. Dachun Sherie V L. Jason P. David A.
Madigan Tufano Wagner Donner Anderson Pilot-Matias Molla Rockway Iwasaki Grampovnik Zhang Krueger Cooper He Kempf Motter Pratt McDaniel Lu Mo Maring Carrick Green Betebenner Liu Masse Shanley DeGoey